🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Altimmune Clinical Study Site
Start Date
2025-05-15
Trial ID
NCT06987513
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
Altimmune Clinical Study Site
Start Date
2025-06-16
Trial ID
NCT07009860
Treatments Being Tested
Purpose of this study is to assess the effects of pemvidutide on NASH resol...
Status
Completed
Location
Altimmune Clinical Study Site
Start Date
2023-07-27
Trial ID
NCT05989711
Treatments Being Tested
This is a Phase 1, open-label, drug-drug interaction (DDI) study of pemvidu...
Status
Completed
Location
CMAX Clinical Research
Start Date
2021-09-15
Trial ID
NCT04972396
Treatments Being Tested
The purpose of the study is to assess the safety and tolerability of ALT-80...
Status
Completed
Location
Headlands Research Scottsdale
Start Date
2021-09-30
Trial ID
NCT05006885
This extension study will assess the safety and effects of 24 weeks of trea...
Status
Completed
Location
Catalina Research Institute
Start Date
2022-03-09
Trial ID
NCT05292911